Literature DB >> 32952431

Anti-MOG Antibody Seropositive Neuromyelitis Optica: A Rare Pediatric Case.

Gonca Koç1, Nurettin Bayram2, Ahmet Sami Güven3, Doğan Bahadır İnan4, Ali Kaya4.   

Abstract

Neuromyelitis Optica spectrum disorder (NMO-SD) is a rare demyelinating disease detected in pediatric patients affecting the primary optic nerve and spinal cord. Clinical findings might overlap with other demyelinating diseases and compare to particularly multiple sclerosis the treatment regimens significantly differ. Therefore, to establish an immediate and definite diagnosis of NMO-SD is crucial. In the majority of patients, the aquaporin-4 antibody is detected in the serum as one of the supporting diagnostic criteria. The antibody against myelin oligodendrocyte glycoprotein (MOG) is recently reported to be associated with serum aquaporin-4 antibody seronegative NMO-SD. Although not included in the diagnostic criteria, we believe that anti-MOG antibody may facilitate the diagnosis of NMO-SD. We herein report a pediatric case of NMO-SD with the anti-MOG antibody seropositivity. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Devic syndrome; Neuromyelitis optica spectrum disorder; anti myelin oligodendrocyte glycoprotein antibody; aquaporin-4 antibody

Year:  2019        PMID： 32952431      PMCID： PMC7481970          DOI： 10.29399/npa.22766

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN： 1300-0667            Impact factor:   1.339


  17 in total

1.  Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.

Authors:  Kevin Rostasy; Simone Mader; Kathrin Schanda; Peter Huppke; Jutta Gärtner; Verena Kraus; Michael Karenfort; Daniel Tibussek; Astrid Blaschek; Barbara Bajer-Kornek; Steffen Leitz; Mareike Schimmel; Franziska Di Pauli; Thomas Berger; Markus Reindl
Journal:  Arch Neurol       Date:  2012-06

2.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

Review 3.  Acute disseminated encephalomyelitis.

Authors:  Silvia Tenembaum; Tanuja Chitnis; Jayne Ness; Jin S Hahn
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

4.  Long-term follow-up of neuromyelitis optica with a pediatric onset.

Authors:  N Collongues; R Marignier; H Zéphir; C Papeix; B Fontaine; F Blanc; D Rodriguez; M Fleury; S Vukusic; J Pelletier; B Audoin; E Thouvenot; W Camu; B Barroso; A Ruet; B Brochet; P Vermersch; C Confavreux; J de Seze
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

6.  Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.

Authors:  K Rostásy; S Mader; E M Hennes; K Schanda; V Gredler; A Guenther; A Blaschek; C Korenke; M Pritsch; D Pohl; O Maier; G Kuchukhidze; M Brunner-Krainz; T Berger; M Reindl
Journal:  Mult Scler       Date:  2012-12-20       Impact factor: 6.312

7.  MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis.

Authors:  C Cassinotto; H Deramond; S Olindo; M Aveillan; D Smadja; P Cabre
Journal:  J Neuroradiol       Date:  2009-02-14       Impact factor: 3.447

8.  CNS aquaporin-4 autoimmunity in children.

Authors:  A McKeon; V A Lennon; T Lotze; S Tenenbaum; J M Ness; M Rensel; N L Kuntz; J P Fryer; H Homburger; J Hunter; B G Weinshenker; K Krecke; C F Lucchinetti; S J Pittock
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

9.  Spectrum of pediatric neuromyelitis optica.

Authors:  Timothy E Lotze; Jennifer L Northrop; George J Hutton; Benjamin Ross; Jade S Schiffman; Jill V Hunter
Journal:  Pediatrics       Date:  2008-10-06       Impact factor: 7.124

10.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Authors:  Lauren B Krupp; Marc Tardieu; Maria Pia Amato; Brenda Banwell; Tanuja Chitnis; Russell C Dale; Angelo Ghezzi; Rogier Hintzen; Andrew Kornberg; Daniela Pohl; Kevin Rostasy; Silvia Tenembaum; Evangeline Wassmer
Journal:  Mult Scler       Date:  2013-04-09       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.